新的可电离性脂质用于非病毒mRNA输送,具有二次氨基循环以太头组
Eric L Dane1, Aditya R Pote1, Martin Hemmerling2
1Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca Boston MA USA eric.dane@astrazeneca.com.
RSC medicinal chemistry
|May 29, 2025
概括
研究人员使用脂质纳米粒子 (LNP) 开发了用于信使核糖核酸 (mRNA) 输送的新型电离性脂质. 这些新型的二次氨基脂比现有的三级氨基脂表现出更好的性能,推进了LNP技术.
科学领域:
- 生物化学 生化学
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
背景情况:
- 脂质纳米粒子 (LNP) 是传递信使核糖核酸 (mRNA) 的关键非病毒载体.
- 电离性脂质是LNP的关键组成部分,调解mRNA相互作用,细胞质递送和组织热带.
- 目前成功的电离性脂质主要利用三级氨基头组进行质子化.
研究的目的:
- 探索二次氨基基基离子化脂质,通过脂质纳米颗粒 (LNP) 增强mRNA传递.
- 通过设计,制造,测试和分析 (DMTA) 方法系统地优化LNP交付效率.
- 为了确定超越基准配方的新型电离性脂质.
主要方法:
- 采用设计,制造,测试和分析 (DMTA) 循环用于电离性脂质的发现.
- 系统地修改了二次氨基脂质结构,包括链条长度,尾部对称性,分支和头部组.
- 配制的信使核糖核酸-脂质纳米颗粒 (mRNA-LNP) 和评估的活体肝蛋白表达.
主要成果:
- 确定了多个具有二次氨基结构的新型电离性脂质候选物.
- 与基准脂质MC3相比,一些新的脂质表现优越.
- 报告的结构-活动关系 (SARs) 显示了对轻微结构修改的敏感性.
结论:
- 二次氨基基基离子化脂质是先进的mRNA输送系统的一个有前途的类别.
- 理性的设计和系统的优化是发现有力的电离性脂质的有效策略.
- 这些二次氨基脂的进一步开发可以显著推进基于LNP的治疗方法.
相关概念视频
Lipids as Anchors
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


